|
bnt162b2 vaccine |
6 |
|
bone marrow aspiration |
6 |
|
cfu-f |
6 |
|
clustering |
6 |
|
genetic risk predisposition |
6 |
|
leukemia |
6 |
|
mesenchymal stromal cell |
6 |
|
vaccine side effect |
6 |
|
vaccine-induced myocarditis |
6 |
|
chronic inflammatory demyelinating polyneuropathy |
5 |
|
comm child health |
5 |
|
neurodevelopment |
5 |
|
attitude |
4 |
|
chinese couple |
4 |
|
concern |
4 |
|
deep learning |
4 |
|
duchenne muscular dystrophy |
4 |
|
fat–water decomposition mri |
4 |
|
neuromuscular disorders |
4 |
|
preimplantation genetic testing |
4 |
|
quantitative mri analysis |
4 |
|
thigh muscle segmentation |
4 |
|
anti-nmda receptor encephalitis |
3 |
|
child |
3 |
|
chinese |
3 |
|
chkb |
3 |
|
founder mutation |
3 |
|
giant mitochondria |
3 |
|
homozygous c4b deficiency |
3 |
|
integrated approach |
3 |
|
klhl40 |
3 |
|
megaconial cmd |
3 |
|
megaconial congenital muscular dystrophy |
3 |
|
muscle biopsy |
3 |
|
nemaline myopathy |
3 |
|
neuromuscular diseases |
3 |
|
nusinersen |
3 |
|
pediatric‐onset |
3 |
|
plasmapheresis |
3 |
|
spinal muscular atrophy |
3 |
|
spinal primitive neuroectodermal tumor |
3 |
|
whole‐exome sequencing |
3 |
|
anti-nmdar encephalitis |
2 |
|
assembly |
2 |
|
autoimmune encephalitis |
2 |
|
brain mri |
2 |
|
cerebellar atrophy |
2 |
|
clinical genetics |
2 |
|
complex i |
2 |
|
congenital muscular dystrophy |
2 |
|
covid19 |
2 |
|
dmd |
2 |
|
dynein cytoplasmic 1 heavy chain 1 (dync1h1) gene |
2 |
|
encephalitis |
2 |
|
epilepsy |
2 |
|
exome sequencing |
2 |
|
family impact |
2 |
|
febrile seizures |
2 |
|
fibromyalgia |
2 |
|
genetics |
2 |
|
health-related quality of life |
2 |
|
hip instability |
2 |
|
hip subluxation |
2 |
|
inflation analysis |
2 |
|
medical help seek-behaviour |
2 |
|
medical sciences |
2 |
|
mitochondrial fusion |
2 |
|
motor |
2 |
|
msto1 |
2 |
|
mtdna depletion |
2 |
|
muscle mri |
2 |
|
muscular dystrophy |
2 |
|
myopathies |
2 |
|
ndufa9 |
2 |
|
neuroimmunology |
2 |
|
neurology |
2 |
|
neuromuscular disorder |
2 |
|
neuromuscular hip |
2 |
|
nmdar antibody |
2 |
|
oral poliomyelitis vaccine |
2 |
|
osteoporosis |
2 |
|
oxphos |
2 |
|
point mutation |
2 |
|
poliomyelitis |
2 |
|
preimplantation genetic diagnosis - china - hong kong |
2 |
|
proxy report |
2 |
|
quality of life |
2 |
|
respiratory |
2 |
|
respiratory tract infections |
2 |
|
spinal muscular atrophy with lower extremity predominance (smaled) |
2 |
|
spinocerebellar ataxia |
2 |
|
telerehabilitation |
2 |
|
tgm6 |
2 |
|
treat-nmd |
2 |
|
vaccine-associated paralytic poliomyelitis |
2 |
|
whole exome sequencing |
2 |
|
acta1 |
1 |
|
adjuvant |
1 |
|
adverse events following immunization (aefi) |
1 |
|
bone density |
1 |
|
bone microarchitecture index |
1 |
|
care recommendation |
1 |
|
clinical practice |
1 |
|
congenital myopathies |
1 |
|
cytoplasmic bodies |
1 |
|
developmental disabilities |
1 |
|
dilated cardiomyopathy |
1 |
|
dystrophin gene |
1 |
|
early onset neonatal sepsis |
1 |
|
epidemiology |
1 |
|
glucocorticoid |
1 |
|
group b streptococcus |
1 |
|
guillain barré syndrome (gbs) |
1 |
|
hr-pqct |
1 |
|
infant, premature |
1 |
|
infant, very low birth weight |
1 |
|
international |
1 |
|
laminin α2 |
1 |
|
laminin α5 |
1 |
|
limb girdle muscular dystrophy |
1 |
|
medicine |
1 |
|
merosin-deficient |
1 |
|
monovalent h1n1 vaccine (h1n1) |
1 |
|
muscular atrophy, spinal |
1 |
|
nationwide population study |
1 |
|
neurologic examination |
1 |
|
newborn screening |
1 |
|
onasemnogene abeparvovec |
1 |
|
organization and administration |
1 |
|
peripheral neuropathy |
1 |
|
pre-symptomatic |
1 |
|
prevalence |
1 |
|
quality of life research |
1 |
|
rare disease registries |
1 |
|
rehabilitation |
1 |
|
risdiplam |
1 |
|
risk factors chinese |
1 |
|
sciene |
1 |
|
self-controlled case-series method (sccs) |
1 |
|
skeletal muscle α-actin |
1 |
|
splice site mutation |
1 |
|
steroid therapy |
1 |
|
utrophin upregulation |
1 |
|
viruses |
1 |
|
x-linked dilated cardiomyopathy |
1 |
